clavicular retatrutide Grey Market GLP-1 Trends and Rise | Akiva Himelhoch posted on the topic Retatrutide for Weight Loss: TRIUMPH-1

The results were striking: women taking GLP-1s showed a 72% improvement in natural pregnancy rates (RR: 1.72, 95% CI 1.22-2.43), meaning they were 1.72 times more likely to conceive naturally compared to the control group

Raverdy V, Baud G, Pigeyre M, Verkindt H, Torres F, Preda C, Thuillier D, Gele P, Vantyghem MC, Caiazzo R, Pattou F

So these medications are more like chronic treatment, like we treat high blood pressure or diabetes. Ali points out that while most side effects of these medications are relatively mild, its still important that anyone considering these drugs consult with a physician

Final pricing depends on medication, dose, and state availability

[DOI] [PMC free article] [PubMed] [Google Scholar] 17.Prisma Executive

Retatrutide Phase 3 (ADA 2026) Key Updates at a Glance By Eli Lilly and Company Retatrutide continues to position itself as one of the most potent obesity therapies in development, demonstrating substantial weight loss while simultaneously improving multiple obesity-related complications